We are live on ! Find out more
TBIO

Translate Bio, Inc. Common Stock
TBIO

Delisted

TBIO was delisted on the 13th of September, 2021.

0 hedge funds and large institutions have $0 invested in Translate Bio, Inc. Common Stock in 2021 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 145 closing their positions.

New
Increased
Maintained
Reduced
Closed

2,500% more call options, than puts

Call options by funds: $104K | Put options by funds: $4K

100% less funds holding

Funds holding: 1450 (-145)

100% less funds holding in top 10

Funds holding in top 10: 40 (-4)

100% less capital invested

Capital invested by funds: $1.85B → $0 (-$1.85B)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 145

Holders
Holders Change
-145
Holders Change %
-100%
% of All Funds
Holding in Top 10
Holding in Top 10 Change
-4
Holding in Top 10 Change %
-100%
% of All Funds
New
Increased
Reduced
Closed
145
Calls
$104K
Puts
$4K
Net Calls
+$100K
Net Calls Change
+$179K
Name Holding Trade Value Shares
Change
Change in
Stake
BG
1
Baupost Group
Massachusetts
-$494M -18,044,239 Closed
Fidelity Investments
2
Fidelity Investments
Massachusetts
-$294M -10,693,161 Closed
BlackRock
3
BlackRock
New York
-$153M -5,552,786 Closed
Vanguard Group
4
Vanguard Group
Pennsylvania
-$106M -3,840,786 Closed
Federated Hermes
5
Federated Hermes
Pennsylvania
-$103M -3,738,001 Closed
State Street
6
State Street
Massachusetts
-$94.6M -3,434,601 Closed
FM
7
Frazier Management
Washington
-$57.4M -2,082,789 Closed
Invesco
8
Invesco
Georgia
-$52.2M -1,894,463 Closed
AVA
9
Atlas Venture Advisors
Massachusetts
-$51.6M -1,872,115 Closed
JP Morgan Chase
10
JP Morgan Chase
New York
-$40.8M -1,480,611 Closed
CCM
11
Camber Capital Management
Massachusetts
-$38.6M -1,400,000 Closed
Geode Capital Management
12
Geode Capital Management
Massachusetts
-$33.3M -1,209,853 Closed
EC
13
EcoR1 Capital
California
-$28.9M -1,048,976 Closed
Goldman Sachs
14
Goldman Sachs
New York
-$28.4M -1,030,039 Closed
T. Rowe Price Associates
15
T. Rowe Price Associates
Maryland
-$25.1M -911,191 Closed
Northern Trust
16
Northern Trust
Illinois
-$19.2M -698,620 Closed
Morgan Stanley
17
Morgan Stanley
New York
-$19.2M -698,131 Closed
RSCM
18
Rock Springs Capital Management
Maryland
-$19.1M -693,266 Closed
Charles Schwab
19
Charles Schwab
California
-$14.5M -524,805 Closed
AG
20
Artal Group
Luxembourg
-$13.8M -500,000 Closed
Macquarie Group
21
Macquarie Group
Australia
-$12.6M -457,565 Closed
DCM
22
DAFNA Capital Management
California
-$10.4M -376,993 Closed
N
23
Nuveen
North Carolina
-$9.13M -331,621 Closed
Citigroup
24
Citigroup
New York
-$6.5M -236,139 Closed
Bank of New York Mellon
25
Bank of New York Mellon
New York
-$6.12M -222,270 Closed

TBIO Hedge Fund Activity: Q3 2021 in Review

0 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Translate Bio, Inc. Common Stock (TBIO) for Q3 2021, worth a combined $0 — down 100% from $1.85B a quarter earlier.

Sellers outnumbered buyers: 145 funds closed out of TBIO and 0 opened new positions — a net loss of 145 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Baupost Group, exiting entirely with an estimated $494M sold.

  • 0 institutional investors held Translate Bio, Inc. Common Stock (TBIO) as of Q3 2021, down from 145 in Q2 2021.
  • Funds reported $0 of Translate Bio, Inc. Common Stock stock for Q3 2021, down 100% quarter-over-quarter.
  • 0 funds opened new Translate Bio, Inc. Common Stock positions in Q3 2021 and 145 closed out, a net change of -145 holders.
  • The largest Translate Bio, Inc. Common Stock seller in Q3 2021 was Baupost Group, an estimated $494M sold.

Based on aggregated 13F filings for Q3 2021.